Financhill
Back

Xcelerate, Inc. 10K Form

Sell
21

XCRT
Xcelerate, Inc.

Last Price:
$0.0100
Seasonality Move:
22.73%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive XCRT News And Ratings

See the #1 stock for the next 7 days that we like better than XCRT

XCRT Financial Statistics

Sales & Book Value

Annual Sales: $2.2M
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $0.00
Price / Book: 0

Profitability

Net Income (TTM): $0
Gross Margin: $333.6K
Return on Equity: 0%
Return on Assets: 0%

Xcelerate, Inc. Earnings Forecast

Key Xcelerate, Inc. Financial Ratios

  • The Gross Profit Margin over the past 19 years for XCRT is 15.03%.
  • The Selling, General & Administrative Expenses for XCRT have been equal to 62.46% of Gross Profit Margin.
  • The Research & Development expenses have been 0.00% of Revenue.
  • The Net Earning history of XCRT is -47.43% of Total Revenues.
  • Per Share Earnings over the last 19 years have been positive in 7 years.

Xcelerate, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Health Care Providers & Services
Sector: Health Care
Current Symbol: XCRT
Website: xcelerate.global

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

XCRT Technical Analysis vs Fundamental Analysis

Sell
21
Xcelerate, Inc. (XCRT) is a Sell

Is Xcelerate, Inc. a Buy or a Sell?

  • Xcelerate, Inc. stock is rated a Sell
    The current Xcelerate, Inc. [XCRT] share price is $0.0088. The Score for XCRT is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.